Test Price
2,800 AED✅ Home Collection Available
MYH11 Gene Familial Thoracic Aortic Aneurysm Type 4 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytic sensitivity for coding region variants via ISO 9001:2015 certified process (certificate: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily 8 AM to 11 PM.
- Clinical Guidance: Post-test telephonic consultation to help interpret results and plan next steps.
- Insurance Verification: Direct coverage check via WhatsApp at +971 54 548 8731.
Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Test Overview & Methodology
This advanced Next-Generation Sequencing (NGS) test analyzes the entire coding region of the MYH11 gene to detect pathogenic variants responsible for familial thoracic aortic aneurysm type 4. It empowers cardiologists and genetic counselors with precise risk stratification, enabling life-saving surveillance and tailored management for patients and at-risk relatives.
| Feature | Our NGS Test | Single-Site Sanger |
|---|---|---|
| Precision | 99.9% analytic sensitivity for all coding variants | High accuracy but only for one known mutation |
| Method | NGS (Next Generation Sequencing) | Sanger sequencing |
| Comprehensiveness | Full gene analysis – detects all pathogenic variants | Targets a single pre-identified familial variant |
| Turnaround Time | 3 to 4 Weeks | 2 to 3 Weeks (limited scope) |
| Clinical Utility | Identifies de novo or unknown mutations | Only confirms a known family mutation |
Physician Insight & Safety Protocols
"As a DHA-licensed Consultant Medical Genetics, I understand the anxiety that can accompany learning about a potential genetic aortic condition. This comprehensive MYH11 analysis provides the clarity needed for proactive echocardiographic surveillance and informed family planning. Always correlate genetic results with clinical imaging and a thorough family history."
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Important Safety Advisory
Do not alter or discontinue any prescribed medications without prior consultation with your treating physician. This test is for risk assessment and does not replace acute medical care.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Minors (<18 years) without legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Exclusion: Individuals unable to provide free and informed consent.
- Emergency Red Flag: Sudden, severe tearing chest or upper back pain, especially radiating to the neck or jaw – call 998 immediately.
- Emergency Red Flag: Signs of aortic dissection: loss of consciousness, stroke-like symptoms, or a significant drop in blood pressure.
Patient FAQ & Clinical Guidance
1. What is the MYH11 genetic test used for?
This test identifies pathogenic mutations in the MYH11 gene associated with familial thoracic aortic aneurysm type 4. Early detection enables proactive imaging surveillance and preventive interventions for both the patient and at-risk relatives.
2. What sample is required and how is it collected?
We accept a simple blood draw (EDTA tube), a single drop of blood on an FTA card, or previously extracted DNA. Collection is performed via our ISO-certified VIP mobile phlebotomy service, available daily from 8 AM to 11 PM with temperature-controlled transport.
3. Will health insurance cover this test?
Many UAE insurers cover genetic testing for familial aortic aneurysm when medically indicated. Our team provides direct billing verification via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
This test and its associated data handling fully comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures and consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information is encrypted, access-controlled, and never shared without explicit authorization.
Clinical & Logistical Metadata
| Test Name | MYH11 Gene Familial Thoracic Aortic Aneurysm Type 4 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), FTA Card, or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | I71.2 (Thoracic aortic aneurysm) |
| LOINC Code | 84388-5 (MYH11 gene mutation analysis) |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians